Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Tide has multiple commercialized drugs—especially targeted injectables and topical/transdermal products—approved in China and abroad. Its flurbiprofen axetil injection has been used clinically for over a decade. The company’s first-in-class small molecule for fibrotic diseases entered Phase I trials in the US. It also develops innovative medical devices such as interventional tricuspid valve repair systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Tide Pharmaceutical.